Concordia Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CONCORDIA, and what generic and branded alternatives to CONCORDIA drugs are available?
CONCORDIA has fifteen approved drugs.
Drugs and US Patents for Concordia
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Concordia | DYRENIUM | triamterene | CAPSULE;ORAL | 013174-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Concordia | PARNATE | tranylcypromine sulfate | TABLET;ORAL | 012342-003 | Aug 16, 1985 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Concordia Pharms Inc | ORAPRED | prednisolone sodium phosphate | SOLUTION;ORAL | 075117-001 | Dec 14, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Concordia Pharms Inc | ORAPRED ODT | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 021959-003 | Jun 1, 2006 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Concordia
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Concordia Pharms Inc | ORAPRED ODT | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 021959-001 | Jun 1, 2006 | 6,740,341 | ⤷ Try a Trial |
Concordia | UROXATRAL | alfuzosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021287-001 | Jun 12, 2003 | 6,149,940*PED | ⤷ Try a Trial |
Concordia Pharms Inc | ORAPRED ODT | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 021959-002 | Jun 1, 2006 | 6,024,981 | ⤷ Try a Trial |
Concordia | PANRETIN | alitretinoin | GEL;TOPICAL | 020886-001 | Feb 2, 1999 | 7,056,954 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CONCORDIA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Tablets | 0.1 mg and 0.2 mg | ➤ Subscribe | 2011-03-04 |
➤ Subscribe | Extended-release Tablets | 10 mg | ➤ Subscribe | 2007-06-12 |
➤ Subscribe | Extended-release Tablets | 0.1 mg and 0.2 mg | ➤ Subscribe | 2011-03-04 |
➤ Subscribe | Orally Disintegrating Tablets | 10 mg, 15 mg and 30 mg | ➤ Subscribe | 2010-07-22 |
Similar Applicant Names
Here is a list of applicants with similar names.